Worldwide incidence of cervical lesions: a systematic review
- PMID: 24877975
- PMCID: PMC9206785
- DOI: 10.1017/S0950268814001356
Worldwide incidence of cervical lesions: a systematic review
Abstract
We conducted a systematic review summarizing data on incidence of high- and low-grade lesions in women with normal baseline cervical cytology, stratified by age (<30 and ⩾30 years), and baseline human papillomavirus (HPV) infection. Incidence of high- and low-grade lesions in women aged ⩾30 years with a baseline HPV infection increased over follow-up time (5-127 months), although incidence generally remained <10%. Without baseline HPV infection, incidence of high-grade lesions remained low over follow-up time (<5% over 5-122 months). Incidence of high-grade lesions in women aged ⩾30 years with baseline HPV infection appeared similar to that in women aged <30 years. In some women aged <30 years, high-grade lesions can develop relatively shortly after initial HPV infection. We observed an increase in low-grade lesions over time in women aged ⩾30 years with baseline HPV infection, potentially indicative of an HPV infection that is potentially progressing to higher grade lesions.
Conflict of interest statement
Jennifer S. Smith has received research grants, served on advisory boards, and/or been a speaker for GlaxoSmithKline, Merck Corporation, Hologic Gen-Probe, Qiagen, and BD Diagnostics. Sylvia M. Taylor is an employee of GlaxoSmithKline.
Figures


Similar articles
-
Prophylactic vaccination against human papillomaviruses to prevent cervical cancer and its precursors.Cochrane Database Syst Rev. 2018 May 9;5(5):CD009069. doi: 10.1002/14651858.CD009069.pub3. Cochrane Database Syst Rev. 2018. PMID: 29740819 Free PMC article.
-
Prevalence of human papillomavirus genotypes among African women with normal cervical cytology and neoplasia: a systematic review and meta-analysis.PLoS One. 2015 Apr 14;10(4):e0122488. doi: 10.1371/journal.pone.0122488. eCollection 2015. PLoS One. 2015. PMID: 25875167 Free PMC article.
-
[Health technology assessment report. Use of liquid-based cytology for cervical cancer precursors screening].Epidemiol Prev. 2012 Sep-Oct;36(5 Suppl 2):e1-e33. Epidemiol Prev. 2012. PMID: 23139163 Italian.
-
Prophylactic vaccination against human papillomavirus infection and disease in women: a systematic review of randomized controlled trials.CMAJ. 2007 Aug 28;177(5):469-79. doi: 10.1503/cmaj.070948. Epub 2007 Aug 1. CMAJ. 2007. PMID: 17671238 Free PMC article.
-
Human papillomavirus testing versus repeat cytology for triage of minor cytological cervical lesions.Cochrane Database Syst Rev. 2013 Mar 28;2013(3):CD008054. doi: 10.1002/14651858.CD008054.pub2. Cochrane Database Syst Rev. 2013. PMID: 23543559 Free PMC article.
Cited by
-
Immune-based biomarker accurately predicts response to imiquimod immunotherapy in cervical high-grade squamous intraepithelial lesions.J Immunother Cancer. 2022 Nov;10(11):e005288. doi: 10.1136/jitc-2022-005288. J Immunother Cancer. 2022. PMID: 36323430 Free PMC article.
-
Tracking vaginal, anal and oral infection in a mouse papillomavirus infection model.J Gen Virol. 2015 Dec;96(12):3554-3565. doi: 10.1099/jgv.0.000295. J Gen Virol. 2015. PMID: 26399579 Free PMC article.
-
Frequency of Human Papilloma Virus (HPV) subtypes 31,33,35,39 and 45 among Yemeni women with cervical cancer.Infect Agent Cancer. 2015 Sep 7;10:29. doi: 10.1186/s13027-015-0026-9. eCollection 2015. Infect Agent Cancer. 2015. PMID: 26347799 Free PMC article.
-
Tumor-induced VEGF-C overexpression in retroperitoneal lymph nodes in VX2 carcinoma-bearing rabbits.Drug Des Devel Ther. 2015 Nov 5;9:5949-56. doi: 10.2147/DDDT.S89810. eCollection 2015. Drug Des Devel Ther. 2015. PMID: 26604693 Free PMC article.
-
Clinical, laboratory and epidemiological aspects of HPV infection in a low-income population from South Bahia, Brazil.Epidemiol Infect. 2017 Dec;145(16):3398-3404. doi: 10.1017/S0950268817002448. Epub 2017 Nov 23. Epidemiol Infect. 2017. PMID: 29166976 Free PMC article.
References
-
- Walboomers JM, et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. Journal of Pathology 1999; 89: 12–19. - PubMed
-
- Smith JS, et al. Human papillomavirus type distribution in invasive cervical cancer and high-grade cervical lesions: a meta-analysis update. International Journal of Cancer 2007; 121: 621–132. - PubMed
-
- Moscicki A, et al. Updating the natural history of HPV and anogenital cancer. Vaccine 2006; 24: S42–51. - PubMed
-
- Cuzick J, et al. Overview of the European and North American studies on HPV testing in primary cervical cancer screening. International Journal of Cancer 2006; 119: 1095–1101. - PubMed
-
- Saslow D, et al. American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer. American Journal of Clinical Pathology 2012; 137: 516–542. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources